Most material SEC filings — August 17, 2026

On August 16, 2026, Dermata Therapeutics (market cap ~$3.1M) sold approximately $3.36M aggregate subscription amount of common stock, pre-funded warrants ($0.001 exercise price, exercisable immediately), Series E common warrants (5-year term, $1.46–$1.47 exercise price), and Series F common warrants (24-month term, $1.46–$1.47 exercise price) to multiple accredited investors under Regulation D Rule 506. Purchasers receive equal treatment, anti-dilution protections, registration rights, and potential liquidated damages for registration delays. The transaction requires stockholder approval for warrant issuance.

Axe Compute and Duos Technologies announced agreements for 55 MW of AI data center capacity across multiple U.S. locations, representing over $500 million in expected aggregate payments. Axe Compute will also acquire 49% equity stakes in project entities via nonbinding term sheets, expanding beyond its Georgia 10 MW deployment. Deployment targeted late 2026 through early 2027, subject to construction and approvals.

Nexalin Technology, Inc. (market cap ~$14.7M) received notice on 2026-08-14 of delisting or failure to satisfy continued listing rules and standards, with transfer of listing. No specific cure details, remediation timeline, or financial metrics disclosed in this 8-K filing.

Aureus Greenway Holdings Inc. (AGH, Nasdaq: PUSA), a ~$26.7M market-cap golf course operator, announced that its proposed business combination with Autonomous Power Corporation (Powerus) received SEC effectiveness of the Form S-4 registration statement on August 12, 2026. The merger is expected to close in early October 2026, subject to remaining conditions; the combined entity will be renamed Powerus Corporation and trade under ticker PUSA. Powerus has announced recent milestones including a ~$2.5M DoD purchase order for 1,500 FPV aircraft, a $90M Air Force IDIQ contract ceiling for Guardian-2 counter-drone systems, and a $30M strategic equity investment from Unusual Machines Inc.

AvalonBay Communities (NYSE: AVB) and Equity Residential (NYSE: EQR) completed their merger of equals on August 17, 2026, creating Vivmark Residential (NYSE: VMRK) with ~$51B equity market cap and ~$70B enterprise value. AvalonBay shareholders received 2.793 shares of Vivmark per AVB share and will own ~51% of the combined company; EQR shareholders own ~49%. The combined entity operates 184,000+ rental apartments with 11,100+ under construction, Dual A3/A- credit ratings, and plans $2B+ annual self-funded growth capacity and $2B+ in combined dividends for 2026.

On June 25, 2026, ENDRA entered into a definitive merger agreement with ASP Isotopes Inc., Noble Africa LLC, and Renergen Limited. Noble Africa will merge with ENDRA's subsidiary and become ENDRA's wholly owned subsidiary; ENDRA will be renamed Noble Africa Inc. A concurrent private placement is expected to generate ~$50 million in gross proceeds, with merger closing anticipated in Q4 2026. ENDRA had $1.7 million cash and $3.8 million restricted cash as of June 30, 2026; Q2 2026 net income was $159,944 (vs. Q2 2025 loss of $1.225 million), primarily driven by $1.6 million in digital asset gains.

Singularity Future Technology Ltd. (Virginia-incorporated public company, ~$4.3M market cap) executed a Securities Purchase Agreement dated August 12, 2026 to issue up to 21,520,803 common shares at $1.394 per share to non-U.S. persons under Regulation S exemption. Aggregate proceeds: approximately $30M (21.52M shares × $1.394). As of agreement date, company had 896,917 shares outstanding; this issuance would dilute existing shareholders by ~2,300% and increase share count to ~22.4M. Proceeds designated for AI computing/supercomputing center construction and business development.

Helix Acquisition Corp. III received a notice of failure to satisfy continued listing rules on 2026-08-14, triggering a delisting process. No specific financial metrics, dollar amounts, or remediation timeline were disclosed in this 8-K filing. This represents a critical corporate event for a SPAC with ~$169M market value.

Duos Technologies' two project entities executed five-year hosting service agreements with Axe Compute Inc. covering 55 MW of AI facility capacity across multiple U.S. data center sites, valued at over $500 million in aggregate contractual base payments (excluding electricity and usage charges). Initial project readiness targeted for late 2026 through early 2027, subject to construction completion and Axe Compute's written acceptance. Nonbinding term sheets also contemplate potential minority investments by Axe Compute in project entities with Duos retaining majority ownership.

Adial Pharmaceuticals completed acquisition of Azora Therapeutics (adding AT177, a colon-targeted AhR agonist for ulcerative colitis) and closed initial $32 million tranche of up to $64 million private placement from biotech investors (including $5.5 million note conversion). Company pivot: from addiction-focused to autoimmune/inflammatory disease focus. Cash position improved to $28.7M as of June 30, 2026 from $4.6M on March 31, 2026; runway extended to second half 2027. Q2 2026 net loss was $52.0M ($11.25/share on 4.6M weighted-avg shares), primarily driven by $46.2M non-cash in-process R&D charge.

Datavault AI Inc. (Delaware corp., public, ~$47.5M market cap) agreed to be acquired by CyberCatch Holdings, Inc. (BC corp.) via arrangement at US$3.22 per share in cash, valuing the company at approximately US$86.2M (based on 26.77M shares outstanding as of agreement date August 17, 2026). The transaction requires court approval (Interim and Final Orders), shareholder vote (two-thirds majority required), and TSXV approval. Company warrants receive no consideration; option holders receive cash equal to (US$3.22 minus exercise price). Outside date: February 17, 2027. Parent will provide US$500K bridge loan. Termination fee payable if company breaches or accepts superior proposal.

On May 18, 2026, Quince Therapeutics acquired Orphai Therapeutics via merger, issuing 67,101 shares of Series C Preferred Stock (convertible to 3.5M common shares) to Orphai stockholders. Concurrently, Quince closed a $115M PIPE on May 21, 2026, selling 144,201 shares of Series C Preferred Stock at $797.50/share and warrants to purchase 72,100 shares at $996.90/share to new and returning investors, generating up to $187M total (including warrant exercise proceeds). Post-conversion, common shares outstanding increase from 1.0M to 12.0M.

On August 17, 2026, Valion Bio received $1.5M from 3i, LP (Initial Closing) for 1,500 Series B Preferred Shares, contingent on CEO Michael Handley's removal. A second $1.5M closing is optional if parties execute a definitive side letter by August 24, 2026. Separately, Valion executed a 10-year royalty agreement with multiple payees (3i, LP and others) obligating Velocity Bioworks subsidiary to pay 5% of gross business revenue quarterly, with Valion guaranteeing payments. The royalty agreement has no dollar cap and runs through 2036.

Fulcrum Therapeutics (NASDAQ: $296.1M market cap) agreed to acquire private biotech Slate Medicines in an all-stock merger dated August 16, 2026. Slate shareholders receive Parent Common Stock at an Exchange Ratio based on a $350M pre-money Company Valuation plus concurrent $245M+ investment. Parent Valuation set at $31.3M (assuming $20.3M Net Cash post-dividend). Merger structure: two-step (First Merger Sub merges into Company, then surviving company merges into Second Merger Sub). Company stockholders and Parent stockholders must each approve. Pre-Closing Cash Dividend to Parent shareholders; concurrent investors funding $245M+.

Abundia Global Impact Group, Inc. (market cap ~$17.9M) obtained a $10 million secured credit facility from Bower Family Holdings, LLC (its largest shareholder) dated August 15, 2026. The facility has a 2-year term, 10% annual interest, with an initial $6.5 million drawdown and optional tranches of $0.5M+ thereafter. Proceeds will repay $4.193M of a convertible note due to Abundia Financial and provide working capital. The debt is secured by company and subsidiary assets via UCC filings and a mortgage.

Check-Cap Ltd (Israeli medical diagnostics company, $7.5M assets) is acquiring MBody AI, an embodied AI robotics-software company, via merger expected Q3 2026. Check-Cap shareholders will own ~10% post-merger; MBody AI shareholders ~90%. Concurrently, Check-Cap is raising $12.5M (1.43M shares at $8.72/share) for merger expenses, robot deployments, and platform development. The company also acquired Ghost Kitchen franchise rights in New Jersey for 1.17M shares on Sept 4, 2025. Pending Nasdaq listing approval; going-concern doubt disclosed.

Kotarba Partners Fund I, LP (Delaware limited partnership, EIN 465728453) filed a Schedule 13D on August 17, 2026, indicating acquisition of beneficial ownership in Jewett Cameron Trading Co Ltd (Oregon-incorporated lumber retailer, market cap ~$9.8M). The filing does not disclose the specific number of shares acquired, percentage ownership achieved, or dollar amount of the investment in the document excerpt provided.

AvalonBay Communities and Equity Residential completed a merger of equals on August 18, 2026, creating Vivmark Residential (NYSE: VMRK), a $51B equity market cap rental housing company. AvalonBay shareholders received 2.793 shares of Vivmark per share held; ownership split ~51% former AvalonBay, ~49% former Equity Residential. The combined entity owns 184,000+ apartments with $4.4B under construction across 33 communities and a $4.2B development rights pipeline.

Ocean Power Technologies' Board announced on August 17, 2026 that it has initiated a comprehensive review of strategic alternatives to maximize stockholder value, retaining Bowen, Inc. as financial advisor. The company will evaluate options to accelerate growth, expand market access, and strengthen financial position across its maritime technology portfolio (PowerBuoy, WAM-V USVs, Merrows). No timetable set; no definitive course of action approved; company will not comment unless board approves action or process concludes.

On March 11, 2026, Sonida Senior Living (SNDA) closed acquisition of CNL Lifestyle Properties (CHP) for ~$1.76B consisting of $404M cash, $772M stock (0.1318 exchange ratio), and $566M CHP debt assumption. SNDA simultaneously raised $110M equity (4M shares) and $1B debt ($525M permanent term loans, $405M revolver increased from prior, $270M bridge); paid $6M for CHP assets and $14.3M disposition fee to adviser CHC; converted all CHP Preferred Stock to common (~2M shares) with $6M cash inducement. Pro forma results for 2025 show $774M revenues, $835M expenses, $150M operating loss.

Prairie Operating Co. executed a Third Amendment to its Amended and Restated Credit Agreement with Citibank (Administrative Agent), KeyBank, MUFG Bank, and UMB Bank, effective June 30, 2026. The amendment relaxes the current ratio covenant (0.50–1.0 for Q2 2026, stepping to 1.0 by Q1 2027), adds a new minimum hydrocarbon production covenant (660–712 BOE/day from August 2026 onward per Schedule 9.23), and imposes bi-weekly 13-week cash flow and accounts-payable reporting. Specific dollar amounts of the credit facility are not disclosed in this amendment excerpt. The borrower released all prior claims against lenders in exchange for the amendment.

L3Harris CEO and Chairman Christopher Kubasik separated from the company effective August 16, 2026, following Board discovery of conduct inconsistent with Company Code of Conduct (unrelated to financial reporting, controls, or operations). Sam Mehta, President of SMS and CSD segments (>80% of revenue), appointed as new President and CEO; Lewis Hay III named Independent Chairman. Kubasik retains 384,825 vested stock options (exercise prices $181.91–$233.51 per share, exercisable for 90 days) and accrued benefits but forfeits all other equity awards and 2026 bonus. 2026 financial guidance reaffirmed.

NRX Pharmaceuticals completed FDA review of its ANDA for preservative-free ketamine (NRX-100) with no major drug deficiencies; sole remaining item is manufacturer's attestation on vial connector, already submitted. Company raised $22.3M gross in public offering, now has $26.7M cash (vs. $7.8M at year-end 2025), and is manufacturing 5M doses for anticipated 2026 commercialization. Additionally, DARPA selected NRX as prime contractor for $11.5M+ SPARC-TMS trial of NRX-101 for depression, potentially expanding addressable market from ~1M to 15M patients.

NexGel reported Q2 2026 revenue of $3.69 million and net loss of $2.87 million (ending June 30, 2026). The company completed its Celularity acquisition in mid-April 2026, forming the BioNX Surgical division, but integration and revenue ramp proceeded slower than anticipated due to ongoing supply chain constraints, resulting in approximately $795,000 backlog. Non-recurring charges included $756,554 in intangible asset amortization, $273,710 in transaction costs, and $144,495 for SilverSeal inventory recall to support hospital market launch. Failed shareholder vote on authorized shares and reverse split (due to broker non-votes) will be re-solicited as standalone proposals by late September 2026.

HomeTrust Bancshares agreed to acquire Blue Ridge Bankshares (Company) in an all-stock merger dated August 16, 2026. Company shareholders will receive 0.086 HomeTrust shares per Company share held, with no cash consideration except for fractional shares. The merger involves two steps: Merger Sub merges into Company, then Company merges into HomeTrust, followed by a subsidiary bank merger. All parties have obtained fairness opinions and executed voting agreements.

HomeTrust Bancshares agreed to acquire Blue Ridge Bankshares in an all-stock merger whereby Blue Ridge shareholders receive 0.086 HomeTrust shares per share held. The transaction is structured as a two-step merger followed by a bank subsidiary merger. As of August 16, 2026, Blue Ridge had 89.7 million shares outstanding; the exchange ratio values the deal at approximately $17M based on HomeTrust's ~$196.9M market cap. Regulatory approvals and shareholder votes are required; closing expected within months.

As of August 16, 2026, Bitmine holds 5,815,164 ETH valued at ~$11.0B (at $1,893/ETH), representing 4.8% of the 120.7M total ETH supply, achieving 96% progress toward its 5% acquisition target. The company repurchased 1.7M common shares in the past week and 20.8M cumulatively since July 2026 under a $4B authorization. Staked ETH totals 5,067,309 tokens ($9.6B), with projected annualized staking revenues of $250M–$287M.

Vulcan Infrastructure & Power announced a $39.4 million private investment in public equity (PIPE) transaction led by Machine Investment Group, Atlas Holdings, and Conversant Capital. Proceeds will redeem approximately $33.1 million in aggregate principal of 8.50% Senior Notes due October 2026, reducing total debt from $36.9 million to $13.7 million (or $3.7 million post-convertible note conversion). The transaction includes a $10 million secured convertible note to Machine at $2.1375/share conversion price. Post-closing, Machine owns ~22.4%, Conversant ~8.3%, Atlas diluted to ~17.0% ownership. The company will issue ~17.1 million PIPE shares at $1.71/share (deal price; stock at $1.84 post-announcement).

FingerMotion, Inc. (public market value ~$72.8M) entered a Securities Purchase Agreement dated August 16, 2026, with Alto Opportunity Master Fund, SPC Segregated Master Portfolio B to issue $4.3M in principal amount of Senior Secured Convertible Notes due August 16, 2027, plus warrants for 4,092,993 shares. Notes are convertible at $0.35/share (fixed), with a 0% interest rate in normal circumstances and 12% if an Event of Default occurs. Lead Investor Alto Opportunity receives pro-rata participation rights in future financings (30% cap), anti-dilution protection, and voting rights. Proceeds are released in three tranches ($1.3M immediately, $2M and $1M subject to note value conditions). Company must obtain stockholder approval to issue shares exceeding 12.256M (19.99% of outstanding shares). Alto Opportunity appointed as Collateral Agent with first-priority security interest in substantially all company assets.

Generation Income Properties (market cap ~$9.4M) regained Nasdaq stockholders' equity compliance on August 10, 2026, after restructuring preferred equity and raising ~$4.6M in June 2026 public offering. Net loss improved 76% YoY to $1.08M in Q2 2026; Loci preferred obligation reduced from ~$20M peak to $7.96M as of August 1, 2026 via profitable asset sales (Dollar Tree $265K gain, Starbucks $825K gain, Vacaville GSA property $301K gain). Company completed 1-for-10 reverse split July 9, 2026 and converted ~$5.3M Series B preferred units to common equity; however, bid-price/market-value delisting risk remains unresolved before Nasdaq Hearings Panel.

Vivmark Residential (formerly Equity Residential) completed a two-step merger of AvalonBay Communities on August 17, 2026. AvalonBay merged into Canopy Merger Sub LLC, which then merged into ERP Operating Limited Partnership. The surviving entity (ERP OP) assumed all debt obligations under multiple indentures covering senior unsecured securities originally issued by AvalonBay. Specific debt amounts are not disclosed in this supplemental indenture filing.

On August 12, 2026, Braemar Hotels & Resorts Inc. completed the sale of the Pier House Resort & Spa in Key West, Florida for $190.0 million in cash. The company received approximately $187.5 million net of selling expenses and repaid $93.7 million in mortgage debt secured by the property. The sale generated an estimated non-recurring gain of $108.6 million for 2025 pro forma purposes.

DocGo Inc. (PubCo) agreed to acquire Hicuity Health, Inc. via merger effective August 16, 2026. Merger consideration consists of 2.0% of PubCo's fully-diluted common stock at closing plus earnout shares equal to 3.5% (vesting if $250M market cap threshold achieved for 30 consecutive trading days within 3 years). Series F Preferred holders receive all consideration; junior preferred and common holders receive nothing, as merger consideration insufficient to satisfy Series F liquidation preference. Parent assumes Perceptive Credit Agreement debt; all junior equity, options, and warrants cancelled without payment.

Black Hills Corporation is acquiring NorthWestern Energy Group in an all-stock transaction with exchange ratio of 0.98 Black Hills shares per NorthWestern share, representing ~$4.4 billion consideration. Merger was signed August 18, 2025; shareholder and most regulatory approvals obtained by June 2026; Montana PSC approval pending. Pro forma combined 2026 H1 revenues $2,124M; combined company will serve ~850K customers across MT, SD, NE.

On June 1, 2026, Chiron Real Estate Inc. acquired The Landing Alexandria (163 units) from Silverstone Alexandria Owner LLC for $130.0M and The Riviera Alexandria (129 units) from Silverstone Alexandria II Owner LLC for $118.9M, totaling $248.9M in cash funded via its credit facility. The Landing's $48.2M mortgage (6.75% fixed, maturing June 2027) was repaid by seller and not assumed. The Riviera, opened March 2026 with 23 of 129 units occupied, had net assets of $119.7M. Pro forma 2025 combined revenue would have been $166.3M; pro forma Q1 2026 net loss attributable to common stockholders was $(4.0)M.

Nocera, Inc. (market cap ~$14.4M) filed an 8-K on August 17, 2026 reporting Item 4.02: Non-Reliance on Previously Issued Financial Statements or Related Audit Report. The filing indicates the company can no longer rely on previously issued financial statements or audit reports. No specific dollar amounts, restatement scope, affected periods, or root causes are disclosed in this document; substantive details appear in exhibits not fully summarized here.

New ERA Energy & Digital (NUAI, $12M market cap) announced Q2 2026 progress: secured TCDC construction and development structure permits in Odessa, Texas; acquired 54-acre corridor (total site now 493 acres); increased Phase 1+2 combined capacity from ~650 MW to ~757 MW (Phase 1: 207 MW, Phase 2: 550 MW); secured $84.8M cash on hand as of June 30, 2026, plus $270M undrawn under Macquarie $290M facility; appointed Charlie Nelson as Chairman/CEO; completed 34.3M share underwritten offering at $3.35/share (raising ~$115M gross); and initiated PPA negotiations to secure direct control of Phase 1 power. Diluted shares outstanding increased from 61.3M to 121.8M.

On August 17, 2026, auditor Fruci Associates II, PLLC issued a letter confirming agreement with Items 4.01 and 4.02 of Netcapital's Form 8-K (changes in accountants and non-reliance on prior financials). The letter does not detail specific dollar amounts, restatement scope, or reasons for the auditor change. The substantive reasons for the change are not disclosed in this exhibit alone.

Chief Executive Officer Seto Wai Yue (TDIC) bought 972K shares (~$3.6M) on the open market (48% of holdings). Open-market insider purchase — historically a bullish signal.

Director Troim Tor Olav (BORR) bought 500K shares (~$2.2M) on the open market (1.7% of holdings). Open-market insider purchase — historically a bullish signal.

InspireMD reported Q2 2026 revenue of $1.8M (flat vs. Q2 2025), but U.S. operations posted a negative $351K due to a voluntary May 2026 recall of the CGuard Prime 135 cm delivery system, which generated $734K in customer credits and $612K inventory impairment. The company hired Kathleen Kennedy as SVP Global Sales & Marketing, commenced CGUARDIANS III trials, and initiated post-quarter cost-reduction actions targeting $9M annual savings. Cash declined 44% to $30.4M (from $54.2M year-end 2025); H1 2026 net loss was $28M. FDA decisions on CGuard Prime 80 cm (TCAR) and original CGuard (CAS) expected later in 2026.

Q2 2026: subscription revenue grew 164% YoY to $764K (now 62% of total revenue vs. 27% prior year); gross profit increased 53% YoY to $610K (49% margin vs. 37%); net loss narrowed to $1.7M from $2.2M. Company regained Nasdaq $1.00 minimum bid price compliance after 10 consecutive trading days at or above $1.00 (July 31–Aug 13, 2026). Cash position: $3.8M as of June 30, 2026.

UNIFI agreed to sell approximately 120 acres of land and 500,000 sq ft of warehouse space across two locations in Yadkin County, North Carolina for ~$60 million gross proceeds (before fees/expenses). The sale is expected to close in Q2 fiscal year, with proceeds allocated to debt reduction and balance sheet optimization. Management states the transaction will have minimal operational impact, with no changes to production capacity or customer service.

Executive Officer & Co-CEO Coppetti Caspar Felix (ONON) bought 65K shares (~$2.0M) on the open market (2.6% of holdings). Open-market insider purchase — historically a bullish signal.

Executive Officer Bernhard Olivier (ONON) bought 65K shares (~$2.0M) on the open market (1.2% of holdings). Open-market insider purchase — historically a bullish signal.

Gray Media (NYSE: GTN) announced on August 17, 2026, an offering of up to $750 million in senior secured first lien notes due 2034. Net proceeds will be used to redeem a portion of its 10.500% senior secured first lien notes due 2029, repay borrowings under its revolving credit facility, and cover offering fees and expenses. The notes will be offered to qualified institutional buyers under Rule 144A and non-U.S. persons under Regulation S.

AI Financial Corporation agreed on July 29, 2026, to sell all shares of Alt 5 Sigma Canada, Inc. (a Quebec subsidiary) to Prime Delta Corp. for $23.55M total consideration: $11.0M four-year promissory note at 4% annual interest plus 11.55M newly issued shares of Prime Delta common stock. AI Financial receives the Prime Delta shares and may use up to 8.55M of them to redeem Series B Preferred Stock on a one-for-one basis from current holders. Prime Delta is backed by guarantees from Jean Francois Amyot (individual), Jason Lake as trustee of Wellington Peel Trust, and Wellington Peel LLC. The note is secured by all Prime Delta assets.

Kaiser Aluminum appointed Fred Stephan as President and CEO effective November 1, 2026, with base salary $1.15M, STI target $1.44M, initial LTI grant $3.77M in RSUs, sign-on grant $2M in RSUs, and total 2027 LTI target $4.43M. Outgoing CEO Keith Harvey (45 years tenure) transitions to Executive Chairman with $0.9M base pay and $0.9M STI target through end of 2027 transition period, plus $2.2M in 2027 LTI. Harvey's severance agreement terminates effective November 1, 2026, superseded by new Key Employee Severance Benefit Plan with enhanced CEO severance multiples: 2.50x for change-in-control terminations, 2.00x for non-CIC terminations.

President and CEO WILSON TROY EDWARD (KURA) bought 100K shares (~$1.1M) on the open market (21% of holdings). Open-market insider purchase — historically a bullish signal.

Kulicke & Soffa appointed Dr. Raj Talluri as President and CEO effective September 1, 2026, with board appointment effective August 17, 2026. Compensation: $750,000 base salary, 110% annual bonus target, $14M new-hire equity grant (50% RSUs/50% PSUs vesting over 36 months), and $6M annual equity award target (40% RSUs/60% PSUs). Additional benefits include $10,000/month housing allowance for 24 months, $100,000 relocation reimbursement, and 24-month severance if terminated without cause. Interim CFO Lester Wong remains in CFO role.